Your browser doesn't support javascript.
loading
Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors.
Böhm, Kevin; Schulze-Niemand, Eric; Kähne, Thilo; Siddiqui, Elisa; Täger, Christian; Ramsbeck, Daniel; Buchholz, Mirko; Naumann, Michael.
Afiliação
  • Böhm K; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany.
  • Schulze-Niemand E; Department of Drug Design and Target Validation MWT, Fraunhofer Institute for Cell Therapy and Immunology IZI, Biocenter, Halle, Germany.
  • Kähne T; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany.
  • Siddiqui E; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany.
  • Täger C; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany.
  • Ramsbeck D; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany.
  • Buchholz M; Department of Drug Design and Target Validation MWT, Fraunhofer Institute for Cell Therapy and Immunology IZI, Biocenter, Halle, Germany.
  • Naumann M; Department of Drug Design and Target Validation MWT, Fraunhofer Institute for Cell Therapy and Immunology IZI, Biocenter, Halle, Germany.
Arch Pharm (Weinheim) ; 356(7): e2200661, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37196427
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Proteases Específicas de Ubiquitina Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Proteases Específicas de Ubiquitina Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article